Lupin 2024

AmerisourceBergen names ABDC, GNP presidents

Print Friendly, PDF & Email

VALLEY FORGE, Pa. — Robert Mauch has been promoted to executive vice president at AmerisourceBergen Corp. and president of AmerisourceBergen Drug Corp. (ABDC).

AmerisourceBergen said Wednesday that with the move, David Neu will transition from his role as ABDC president to the newly created position of executive vice president of retail Strategy and president of Good Neighbor Pharmacy (GNP), the pharmaceutical distributor’s community pharmacy network.

Most recently, Mauch was senior vice president and chief operating officer for ABDC. Before that, he served AmerisourceBergen in numerous positions. He was the founder and President of Xcenda, which was acquired by AmerisourceBergen in 2007, and has held various leadership positions at AmerisourceBergen, including senior vice president roles for ABDC alternate care sales, ABDC sales and ABDC operations.

"Bob has demonstrated tremendous leadership, and his powerful strategic thinking has played a significant role in enabling AmerisourceBergen to deliver on our promise to be a global health care solutions leader," AmerisourceBergen president and chief executive officer Steven Collis said in a statement. "In his new role, Bob’s innovative, customer-centric vision will further our efforts to support pharmaceutical manufacturers and health care providers as they work to drive the best outcomes for patients."

Neu has more than 30 years of industry experience, holding senior positions at General Foods Corp., The L.A. Drug Co. and Bergen Brunswig before joining AmerisourceBergen Drug Corp.

"I am very pleased that Dave will focus his considerable energy and expertise on further strengthening AmerisourceBergen’s programs and services for retail pharmacy," Collis stated. "The evolving health care landscape has created unprecedented opportunities to elevate the role of community pharmacy. With Dave’s longstanding commitment to Good Neighbor Pharmacy and the independent pharmacists we serve, combined with his demonstrated leadership in fostering innovative partnerships throughout the pharmaceutical supply chain, we are very well positioned to continue to drive tremendous value for all of our stakeholders."


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21